A carregar...

Phase II Trial of Pyrazoloacridine in Children With Solid Tumors: A Pediatric Oncology Group Phase II Study

PURPOSE: Pyrazoloacridine (PZA), a rationally synthesized deoxyribonucleic acid (DNA) binding agent that preferentially inhibits ribonucleic acid rather than DNA synthesis, is active against hypoxic and noncycling tumor cells and has greater in vitro activity against a broad range of human solid tum...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Berg, Stacey L., Blaney, Susan M., Sullivan, James, Bernstein, Mark, Dubowy, Ronald, Harris, Michael B.
Formato: Artigo
Idioma:Inglês
Publicado em: 2000
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4008246/
https://ncbi.nlm.nih.gov/pubmed/11132217
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!